| Product Name | MF | CAS | Details |
|---|
| lifitegrast;;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6- carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic | C29H24Cl2N2O7S | 1025967-78-5 | Details |
| Avibactam Sodium impurities G | Details |
| Revefenacin | C35H43N5O4 | 864750-70-9 | Details |
| Ivabradine IMpurity | C27H35ClN2O6 | 1616710-50-9 | Details |
| 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | C21H27N3O2 | 743460-48-2 | Details |
| Rotigotine;;(6S)-6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol | C19H25NOS | 99755-59-6 | Details |
| Cabotegravir (GSK744, GSK1265744) | C19H17F2N3O5 | 1051375-10-0 | Details |
| biphenyl-2-yl-carbamic acid 1-[2-(benzylmethylamino)ethyl]piperidin-4-yl ester | C28H33N3O2 | 864686-28-2 | Details |
| Baloxavir | C24H19F2N3O4S | 1985605-59-1 | Details |
| 4-piperidyl N-(2-biphenyl)carbamate | C18H20N2O2 | 171722-92-2 | Details |
| 2-(N-benzyl-N-methylamino)ethyl chloride hydrochloride | C10H15Cl2N | 23510-18-1 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| Finerenone (BAY 94-8862) | C21H22N4O3 | 1050477-31-0 | Details |
| vericiguat | C19H16F2N8O2 | 1350653-20-1 | Details |
| Impurity D | C23H28N4O4 | 2640280-83-5 | Details |
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate | C12H9NO8 | 173604-87-0 | Details |
| (2S-trans)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic acid | C4H8N2O4S | 80082-65-1 | Details |
| 2-Mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | C20H22N4O4S3 | 89604-92-2 | Details |
| N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester | C29H33N3O4 | 1682660-39-4 | Details |
| 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester | C16H15F2NO4 | 112811-71-9 | Details |
| Moxifloxacin hydrochloride | C21H25ClFN3O4 | 186826-86-8 | Details |
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl- | C20H19N3O4 | 2640280-86-8 | Details |
| Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- | C14H18N2O3 | 938143-02-3 | Details |
| Impurity A | C22H26N4O4 | 2640280-82-4 | Details |
| (2S,5R)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide 7-oxo-6-(sulfoxy)monosodium salt | C7H12N3NaO6S | 1192491-61-4 | Details |
| ZVPVPYWMFMUFEZ-UHFFFAOYSA-N | C35H42N4O5 | 909800-36-8 | Details |
| 4,4'-Dimethylbiphenyl | C14H14 | 613-33-2 | Details |
| LeterMovir | C29H28F4N4O4 | 917389-32-3 | Details |
| Larotrectinib | C21H24F2N6O6S | 1223405-08-0 | Details |
| N-benzyl-2-chloro-N-methyl-ethanamine | C10H14ClN | 17542-47-1 | Details |
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)- | C22H23N3O4 | 2640280-87-9 | Details |
| 4-Benzoylmorpholine | C11H13NO2 | 1468-28-6 | Details |
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl- | C21H20N4O3 | 2084136-51-4 | Details |
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl- | C20H20N4O3 | 2640280-84-6 | Details |
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)- | C22H24N4O3 | 2640280-85-7 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||